Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus. (18th March 2008)

• Record Type: Journal Article
• Authors: Khemtémourian, Lucie; Antoinette Killian, J.; Höppener, Jo W. M.; Engel, Maarten F. M.
• Other Names: Westermark Per Academic Editor.
• Is Part Of: Experimental diabetes research. Volume 2008(2008)
• Publication Date: 2008-03-18
• Subjects: Diabetes -- Research -- Periodicals; Diabetes -- Research; Periodicals; 616.462
• DOI: 10.1155/2008/421287
• Languages: English
• ISSNs: 1687-5214

Abstract

Abstract : The presence of fibrillar protein deposits (amyloid) of human islet amyloid polypeptide (hIAPP) in the pancreatic islets of Langerhans is thought to be related to death of the insulin-producing isletβ -cells in type 2 diabetes mellitus (DM2). The mechanism of hIAPP-inducedβ -cell death is not understood. However, there is growing evidence that hIAPP-induced disruption ofβ -cell membranes is the cause of hIAPP cytotoxicity. Amyloid cytotoxicity by membrane damage has not only been suggested for hIAPP, but also for peptides and proteins related to other misfolding diseases, like Alzheimer_s disease, Parkinson's disease, and prion diseases. Here we review the interaction of hIAPP with membranes, and discuss recent progress in the field, with a focus on hIAPP structure and on the proposed mechanisms of hIAPP-induced membrane damage in relation toβ -cell death in DM2.